T0	Participants 168 243	patients with multiple myeloma and low peripheral blood CD34(+) cell count:
T1	Participants 504 535	patients with multiple myeloma.
T2	Participants 976 1089	patients with multiple myeloma, stratified by preapheresis PB CD34(+) cell count: <10, <15, <20, and ≥20 cells/μL